SCHEMBL28891696

SCHEMBL28891696

Nc1cc(OCC2(O)CCN(c3ccc(Cl)cc3F)CC2)c2c(c1F)NC(=O)CC2

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 6/20 0.37
▸ GRM5 P41594 1/20 0.33
▸ TRPM8 Q7Z2W7 2/20 0.33
▸ DDB1 Q16531 4/20 0.32
▸ CRBN Q96SW2 4/20 0.32
▸ SLC6A2 P23975 4/20 0.31
▸ SLC6A4 P31645 4/20 0.31
▸ SLC6A3 Q01959 4/20 0.31
▸ KCNH2 Q12809 2/20 0.31
▸ CCR1 P32246 1/20 0.30
▸ METAP2 P50579 2/20 0.30
▸ IKZF3 Q9UKT9 3/20 0.30
▸ DRD2 P14416 1/20 0.30
▸ ADRA1D P25100 1/20 0.30
▸ ADRA1A P35348 1/20 0.30
▸ ADRA1B P35368 1/20 0.30
▸ F10 P00742 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17543819 0.99 TRPV4 (0.36) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17542718 0.92 TRPV4 (0.38) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17543057 0.91 TRPV4 (0.39) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17543733 0.90 TRPV4 (0.37) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17544054 0.90 TRPV4 (0.37) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17543786 0.89 TRPV4 (0.38) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17543156 0.88 TRPV4 (0.39) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17543977 0.88 TRPV4 (0.36) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17542898 0.88 TRPV4 (0.38) TRPV4GRM5TRPM8DDB1CRBN
SCHEMBL17544103 0.88 TRPV4 (0.40) TRPV4GRM5TRPM8DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795117-B Heterobicyclic compounds and their use for the treatment of tuberculosis 大塚制药株式会社 2020-06-26 — — CN disclosed
Send feedback